Literature DB >> 7236321

Increased incidence of cervical atypia in women with systemic lupus erythematosus treated with chemotherapy.

G Nyberg, O Eriksson, N G Westberg.   

Abstract

In a retrospective study we found that 19 of 80 women with systemic lupus erythematosus had atypical cervical smears as compared to only 9 of 80 age-matched women without the disease. This increased incidence occurred mainly among women receiving cytotoxic drugs. Cervical atypia in women with lupus was not morphologically different from cervical atypia in general. Possible mechanisms responsible for the increased incidence are discussed. It is concluded that women with lupus who receive chemotherapy should have cervical smears taken regularly.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7236321     DOI: 10.1002/art.1780240503

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  13 in total

Review 1.  Recognition and management of systemic lupus erythematosus.

Authors:  J O Schroeder; H H Euler
Journal:  Drugs       Date:  1997-09       Impact factor: 9.546

Review 2.  Systemic lupus erythematosus, human papillomavirus infection, cervical pre-malignant and malignant lesions: a systematic review.

Authors:  Iuri Usêda Santana; Alline do Nascimento Gomes; Leomar D'Cirqueira Lyrio; Maria Fernanda Rios Grassi; Mittermayer Barreto Santiago
Journal:  Clin Rheumatol       Date:  2010-10-31       Impact factor: 2.980

Review 3.  Revisiting the issue of malignancy risk in systemic lupus erythematosus.

Authors:  Sasha Bernatsky; Rosalind Ramsey-Goldman; Ann E Clarke
Journal:  Curr Rheumatol Rep       Date:  2005-12       Impact factor: 4.592

4.  Correlation between systemic lupus erythematosus and malignancies: a cross-sectional population-based study.

Authors:  Shir Azrielant; Shmuel Tiosano; Abdulla Watad; Naim Mahroum; Aaron Whitby; Doron Comaneshter; Arnon D Cohen; Howard Amital
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

Review 5.  A review on SLE and malignancy.

Authors:  May Y Choi; Kelsey Flood; Sasha Bernatsky; Rosalind Ramsey-Goldman; Ann E Clarke
Journal:  Best Pract Res Clin Rheumatol       Date:  2017-11-10       Impact factor: 4.098

6.  Risk of high-grade cervical dysplasia and cervical cancer in women with systemic lupus erythematosus receiving immunosuppressive drugs.

Authors:  C H Feldman; J Liu; S Feldman; D H Solomon; S C Kim
Journal:  Lupus       Date:  2016-10-31       Impact factor: 2.911

Review 7.  Malignancy and systemic lupus erythematosus.

Authors:  Sasha Bernatsky; Ann Clarke; Rosalind Ramsey-Goldman
Journal:  Curr Rheumatol Rep       Date:  2002-08       Impact factor: 4.592

8.  Prevalence of human papilloma virus infections and cervical cytological abnormalities among Korean women with systemic lupus erythematosus.

Authors:  You-Hyun Lee; Jung-Yoon Choe; Sung-Hoon Park; Yong-Wook Park; Shin-Seok Lee; Young-Mo Kang; Eon-Jeong Nam; Won Park; Seong-Ryul Kwon; Sang-Cheol Bae; Yun-Jung Kim; Chang-Hee Suh; Hyoun-Ah Kim; Nam Wook Hur; Jisoo Lee
Journal:  J Korean Med Sci       Date:  2010-09-17       Impact factor: 2.153

9.  Systemic lupus erythematosus associated with primary large cell carcinoma of the lung.

Authors:  H Irie; H Satoh; T Akama; Y T Yamashita; H Ishikawa; M Ohtsuka
Journal:  Med Oncol       Date:  1998-12       Impact factor: 3.064

Review 10.  Malignancies in systemic lupus erythematosus.

Authors:  Emese Kiss; Laszlo Kovacs; Peter Szodoray
Journal:  Autoimmun Rev       Date:  2009-07-27       Impact factor: 9.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.